HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Zhao Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

3/2024[First-line Treatment with Furmonertinib Mesylate in Lung Adenocarcinoma Patient 
with EGFR Exon 20 Insertion Mutantion].
12/2023HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.
2/2023Correction : LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
9/2022Targeting co-delivery of doxorubicin and gefitinib by biotinylated Au NCs for overcoming multidrug resistance in imaging-guided anticancer therapy.
3/2022A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI.
1/2022Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
11/2021LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway.
9/2021circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1.
4/2021Trichostatin A downregulates bromodomain and extra-terminal proteins to suppress osimertinib resistant non-small cell lung carcinoma.
1/2021Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Zhao Research Topics

Disease

282Neoplasms (Cancer)
04/2024 - 07/2003
65Inflammation (Inflammations)
01/2024 - 01/2009
59Infections
04/2024 - 08/2002
37Neoplasm Metastasis (Metastasis)
01/2024 - 09/2003
36Breast Neoplasms (Breast Cancer)
04/2024 - 07/2004
35Hepatocellular Carcinoma (Hepatoma)
04/2023 - 01/2004
34Carcinogenesis
05/2024 - 09/2003
30Hypoxia (Hypoxemia)
05/2024 - 10/2009
30Chronic Obstructive Pulmonary Disease (COPD)
04/2024 - 11/2004
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 07/2010
23Fibrosis (Cirrhosis)
04/2024 - 01/2004
23Body Weight (Weight, Body)
02/2024 - 08/2008
23Wounds and Injuries (Trauma)
12/2023 - 10/2002
21Hypertension (High Blood Pressure)
12/2023 - 03/2006
20Diabetic Nephropathies (Diabetic Nephropathy)
02/2024 - 01/2014
20Leukemia
02/2024 - 09/2005
20Carcinoma (Carcinomatosis)
10/2023 - 09/2003
18Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 12/2005
18Insulin Resistance
04/2024 - 05/2005
17Alzheimer Disease (Alzheimer's Disease)
01/2024 - 10/2006
17Lung Neoplasms (Lung Cancer)
11/2022 - 12/2007
16Type 2 Diabetes Mellitus (MODY)
04/2024 - 01/2012
16Obesity
02/2024 - 08/2011
15Pneumonia (Pneumonitis)
02/2024 - 03/2010
15Cognitive Dysfunction
01/2024 - 01/2014
15Ischemia
10/2023 - 01/2005
15COVID-19
01/2023 - 01/2020
14Hemorrhage
05/2024 - 02/2013
14Pain (Aches)
03/2024 - 11/2012
14Thyroid Neoplasms (Thyroid Cancer)
10/2023 - 07/2008
13Brain Ischemia (Cerebral Ischemia)
07/2023 - 01/2005
13Stomach Neoplasms (Stomach Cancer)
11/2022 - 06/2005
12Atherosclerosis
05/2024 - 07/2009
12Colonic Neoplasms (Colon Cancer)
01/2024 - 08/2012
12Glioblastoma (Glioblastoma Multiforme)
12/2023 - 03/2008
12Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2015
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 03/2014
11Acute Kidney Injury (Acute Renal Failure)
12/2023 - 09/2012
10Acute Lung Injury
11/2023 - 09/2012
9Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 07/2009
9Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 08/2010
9Melanoma (Melanoma, Malignant)
10/2023 - 08/2010
9Neurodegenerative Diseases (Neurodegenerative Disease)
08/2023 - 01/2014
9Prostatic Neoplasms (Prostate Cancer)
02/2023 - 01/2012
9Cysts
01/2023 - 08/2010
9Periodontitis
01/2023 - 10/2014
9Stroke (Strokes)
12/2022 - 12/2005
8Neuroinflammatory Diseases
05/2024 - 04/2018

Drug/Important Bio-Agent (IBA)

119Proteins (Proteins, Gene)FDA Link
04/2024 - 07/2003
43Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2010
36Glucose (Dextrose)FDA LinkGeneric
01/2024 - 01/2014
29Messenger RNA (mRNA)IBA
01/2023 - 09/2003
23FlavonoidsIBA
12/2023 - 12/2006
23DNA (Deoxyribonucleic Acid)IBA
12/2023 - 10/2005
23CytokinesIBA
08/2023 - 08/2010
21LipidsIBA
11/2023 - 12/2005
20MicroRNAs (MicroRNA)IBA
04/2024 - 01/2012
20wogoninIBA
01/2022 - 06/2006
19Phosphotransferases (Kinase)IBA
04/2024 - 04/2005
19Long Noncoding RNAIBA
01/2024 - 01/2017
19VaccinesIBA
02/2023 - 07/2003
18EnzymesIBA
04/2024 - 08/2004
18Interleukin-6 (Interleukin 6)IBA
12/2023 - 08/2010
18Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 08/2014
18CateninsIBA
11/2023 - 11/2010
16Therapeutic UsesIBA
05/2024 - 04/2011
165,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
11/2020 - 12/2006
15SmokeIBA
06/2021 - 10/2002
13Oxygen (Dioxygen)IBA
05/2024 - 11/2004
13Small Interfering RNA (siRNA)IBA
04/2024 - 09/2007
13RNA (Ribonucleic Acid)IBA
03/2024 - 08/2014
13Antiviral Agents (Antivirals)IBA
09/2023 - 09/2008
12LipopolysaccharidesIBA
08/2023 - 01/2009
12Peptides (Polypeptides)IBA
01/2023 - 12/2010
11Transcription Factors (Transcription Factor)IBA
05/2024 - 01/2015
11Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
04/2024 - 01/2012
11Indicators and Reagents (Reagents)IBA
03/2024 - 02/2011
11Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 08/2009
11polyglycerolIBA
12/2023 - 07/2014
11Blood Glucose (Blood Sugar)IBA
07/2022 - 08/2008
11Cisplatin (Platino)FDA LinkGeneric
10/2021 - 03/2013
10Neuroprotective AgentsIBA
05/2024 - 02/2014
10Uric Acid (Urate)IBA
04/2024 - 01/2017
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2023 - 05/2005
10AntigensIBA
05/2022 - 07/2004
9salicylhydroxamic acid (SHAM)IBA
05/2024 - 03/2012
9CreatinineIBA
12/2023 - 08/2015
9AlbuminsIBA
12/2023 - 01/2019
9ChemokinesIBA
10/2023 - 01/2018
9Hormones (Hormone)IBA
05/2023 - 01/2018
9AntioxidantsIBA
01/2022 - 05/2010
9NanodiamondsIBA
09/2021 - 07/2014
9gambogic acidIBA
06/2009 - 07/2004
8Hematoxylin (Haematoxylon)IBA
03/2024 - 01/2012

Therapy/Procedure

124Therapeutics
04/2024 - 12/2005
43Drug Therapy (Chemotherapy)
04/2024 - 12/2005
14Aftercare (After-Treatment)
05/2024 - 11/2008
10Radiotherapy
10/2023 - 07/2013
9Immunotherapy
03/2024 - 01/2004
9Artificial Respiration (Mechanical Ventilation)
01/2024 - 09/2018